| Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing PL Lin, CB Ford, MT Coleman, AJ Myers, R Gawande, T Ioerger, ... Nature medicine 20 (1), 75-79, 2014 | 544 | 2014 |
| Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis CB Ford, RR Shah, MK Maeda, S Gagneux, MB Murray, T Cohen, ... Nature genetics 45 (7), 784-790, 2013 | 512 | 2013 |
| Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection CB Ford, PL Lin, MR Chase, RR Shah, O Iartchouk, J Galagan, ... Nature genetics 43 (5), 482-486, 2011 | 509 | 2011 |
| The evolution of drug resistance in clinical isolates of Candida albicans CB Ford, JM Funt, D Abbey, L Issi, C Guiducci, DA Martinez, T Delorey, ... Elife 4, e00662, 2015 | 291 | 2015 |
| SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection P Feuerstadt, TJ Louie, B Lashner, EEL Wang, L Diao, JA Bryant, M Sims, ... New England Journal of Medicine 386 (3), 220-229, 2022 | 270 | 2022 |
| Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial EW Yu, L Gao, P Stastka, MC Cheney, J Mahabamunuge, M Torres Soto, ... PLoS medicine 17 (3), e1003051, 2020 | 229 | 2020 |
| Magnetic barcode assay for genetic detection of pathogens M Liong, AN Hoang, J Chung, N Gural, CB Ford, C Min, RR Shah, ... Nature communications 4 (1), 1752, 2013 | 199 | 2013 |
| SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial BH McGovern, CB Ford, MR Henn, DS Pardi, S Khanna, EL Hohmann, ... Clinical infectious diseases 72 (12), 2132-2140, 2021 | 122 | 2021 |
| Mycobacterium tuberculosis–heterogeneity revealed through whole genome sequencing C Ford, K Yusim, T Ioerger, S Feng, M Chase, M Greene, B Korber, ... Tuberculosis 92 (3), 194-201, 2012 | 116 | 2012 |
| Expression of the Helicobacter pylori adhesin SabA is controlled via phase variation and the ArsRS signal transduction system AC Goodwin, DM Weinberger, CB Ford, JC Nelson, JD Snider, JD Hall, ... Microbiology 154 (8), 2231-2240, 2008 | 107 | 2008 |
| DNA replication fidelity in Mycobacterium tuberculosis is mediated by an ancestral prokaryotic proofreader JM Rock, UF Lang, MR Chase, CB Ford, ER Gerrick, R Gawande, ... Nature genetics 47 (6), 677-681, 2015 | 80 | 2015 |
| Computational Modeling Predicts IL-10 Control of Lesion Sterilization by Balancing Early Host Immunity–Mediated Antimicrobial Responses with Caseation during Mycobacterium … NA Cilfone, CB Ford, S Marino, JT Mattila, HP Gideon, JAL Flynn, ... The Journal of Immunology 194 (2), 664-677, 2015 | 72 | 2015 |
| A phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis MR Henn, EJ O’Brien, L Diao, BG Feagan, WJ Sandborn, C Huttenhower, ... Gastroenterology 160 (1), 115-127. e30, 2020 | 66 | 2020 |
| Coordinated host-pathogen transcriptional dynamics revealed using sorted subpopulations and single macrophages infected with Candida albicans JF Muñoz, T Delorey, CB Ford, BY Li, DA Thompson, RP Rao, CA Cuomo Nature communications 10 (1), 1607, 2019 | 66 | 2019 |
| Rifampin resistance mutations are associated with broad chemical remodeling of Mycobacterium tuberculosis N Lahiri, RR Shah, E Layre, D Young, C Ford, MB Murray, SM Fortune, ... Journal of Biological Chemistry 291 (27), 14248-14256, 2016 | 63 | 2016 |
| Distinct Effects on Diversifying Selection by Two Mechanisms of Immunity against Streptococcus pneumoniae Y Li, T Gierahn, CM Thompson, K Trzciński, CB Ford, N Croucher, ... PLoS pathogens 8 (11), e1002989, 2012 | 54 | 2012 |
| Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection C Normington, IB Moura, JA Bryant, DJ Ewin, EV Clark, MJ Kettle, ... NPJ biofilms and microbiomes 7 (1), 16, 2021 | 50 | 2021 |
| The mutation rate of mycobacterial repetitive unit loci in strains of M. tuberculosis from cynomolgus macaque infection MN Ragheb, CB Ford, MR Chase, PL Lin, JAL Flynn, SM Fortune BMC genomics 14 (1), 145, 2013 | 29 | 2013 |
| SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI) S Khanna, M Sims, TJ Louie, M Fischer, K LaPlante, J Allegretti, ... Antibiotics 11 (9), 1234, 2022 | 23 | 2022 |
| Transcriptional heterogeneity of Cryptococcus gattii VGII compared with non-VGII lineages underpins key pathogenicity pathways RA Farrer, CB Ford, J Rhodes, T Delorey, RC May, MC Fisher, ... Msphere 3 (5), 2018 | 14 | 2018 |
Thomas R IoergerProfessor of Computer Science, Texas A&M UniversityGeverifieerd e-mailadres voor cs.tamu.edu
